Cargando…
A Novel Chemically Modified Curcumin Reduces Severity of Experimental Periodontal Disease in Rats: Initial Observations
Tetracycline-based matrix metalloproteinase- (MMP-) inhibitors are currently approved for two inflammatory diseases, periodontitis and rosacea. The current study addresses the therapeutic potential of a novel pleiotropic MMP-inhibitor not based on an antibiotic. To induce experimental periodontitis,...
Autores principales: | Elburki, Muna S., Rossa, Carlos, Guimaraes, Morgana R., Goodenough, Mark, Lee, Hsi-Ming, Curylofo, Fabiana A., Zhang, Yu, Johnson, Francis, Golub, Lorne M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101223/ https://www.ncbi.nlm.nih.gov/pubmed/25104884 http://dx.doi.org/10.1155/2014/959471 |
Ejemplares similares
-
A Novel Chemically Modified Curcumin “Normalizes” Wound-Healing in Rats with Experimentally Induced Type I Diabetes: Initial Studies
por: Zhang, Yazhou, et al.
Publicado: (2016) -
Enhanced efficacy of chemically modified curcumin in experimental periodontitis: systemic implications
por: Wang, Howard H, et al.
Publicado: (2019) -
Chemically-Modified Curcumin 2.24: A Novel Systemic Therapy for Natural Periodontitis in Dogs
por: Deng, Jie, et al.
Publicado: (2020) -
Inhibition of anthrax lethal factor by curcumin and chemically modified curcumin derivatives
por: Antonelli, Anthony C., et al.
Publicado: (2014) -
A Novel Modified-Curcumin Promotes Resolvin-Like Activity and Reduces Bone Loss in Diabetes-Induced Experimental Periodontitis
por: Deng, Jie, et al.
Publicado: (2021)